TruScreen Group (ASX:TRU) has launched a Vietnam-based program that will facilitate the testing of 260,000 women for cervical cancer using the company’s AI-enabled, non-invasive screening technology.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
The program – which represents a partnership between TruScreen, Ho Chi Minh City Public Health Association (HPHA), and distributor Gorton Health – is part of a wider government initiative to ensure 60% of women aged 30 to 54 in Vietnam become screened for the cancer.
Right now, that number stands closer to around 25% of all Vietnamese women.
“This program may save the lives of over 2,600 mothers, daughters, sisters, wives, and friends,” TruScreen CEO Marty Dillon said.
“TruScreen was identified as the ideal screening technology for its unique ability to provide accurate, real-time results without the need for any expensive laboratory infrastructure and its portability, which allows for the program to ‘go to the community,’ increasing screening uptake amongst the women of Ho Chi Minh City.”
The three joint parties signed a tripartite Memorandum of Understanding in November 2024, with the program beginning on April 12 in Ho Chi Minh City.
More market news
Kowtow: “Biggest day in financial history” on Trump’s tariffs retreat
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
He continued: “This HPHA screening program will also serve as an important reference site for neighbouring countries who may be considering a similar large-scale screening program to improve Women’s Health.”
TRU has been trading at 2.6 cents heading into Week 17.
Join the discussion: See what HotCopper users are saying about TruScreen Group and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.